Regenerative Medical Technology (RMTG) Capital Expenditures (2022 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Capital Expenditures of $315394.0 for Q1 2026, up 18.05% quarter-over-quarter from $267172.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Capital Expenditures (2022 - 2026) Analysis & Trends
Regenerative Medical Technology's Capital Expenditures history runs 5 years deep, the most recent figure standing at $315394.0 for Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $315394.0; the TTM figure through Mar 2026 stood at $857395.0 (changed N/A YoY), while the FY2025 annual figure was $602583.0, up 179.73% from the prior year.
- Capital Expenditures for Q1 2026 stood at $315394.0, up from $267172.0 in the prior quarter.
- The five-year high for Capital Expenditures was $315394.0 in Q1 2026, with the low at $1262.0 in Q3 2022.
- The 5-year median for Capital Expenditures is $59154.0 (2024), against an average of $113707.6.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures jumped 7141.44% in 2023, then tumbled 82.39% in 2024.
- Regenerative Medical Technology's Capital Expenditures stood at $68527.0 in 2022, then soared by 314.44% to $284002.0 in 2023, then sank by 82.39% to $50000.0 in 2024, then jumped by 434.34% to $267172.0 in 2025, then rose by 18.05% to $315394.0 in 2026.
- Business Quant data shows RMTG's Capital Expenditures at $315394.0 in Q1 2026, $267172.0 in Q4 2025, and $224829.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 315,394.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315,394.00 |
| Mar 31, 2026 | 315,394.00 |
| Dec 31, 2025 | 267,172.00 |
| Dec 31, 2025 | 267,172.00 |
| Sep 30, 2025 | 224,829.00 |
| Sep 30, 2025 | 224,829.00 |
| Dec 31, 2024 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 53,608.00 |
| Sep 30, 2024 | 53,608.00 |
| Jun 30, 2024 | 52,657.00 |
| Jun 30, 2024 | 52,657.00 |
| Mar 31, 2024 | 59,154.00 |
| Mar 31, 2024 | 59,154.00 |
| Dec 31, 2023 | 284,002.00 |
| Dec 31, 2023 | 284,002.00 |
| Sep 30, 2023 | 91,387.00 |
| Sep 30, 2023 | 91,387.00 |
| Jun 30, 2023 | 4,721.00 |
| Jun 30, 2023 | 4,721.00 |